Intratumor heterogeneity describes phenomena that cancer cells from a single focal population can be highly diverse in morphology, gene expression, metabolism, motility, proliferation, metastatic potential, and drug sensitivity ([@ref2]). The heterogeneity is the consequence of cancer evolution and the major cause of therapeutic failure due to drug resistance ([@ref2]). Theoretically, multi-target combination therapy may eliminate heterogeneous cancer cells but may also induce severe side effects and promote the genesis of novel malignancy. Therefore, further investigations on the pattern and mechanism of cancer heterogeneity are required, with the hope to better refine the treatment strategies. However, there is lack of appropriate *in vivo* cancer models for simulating multidimensional heterogeneity. Patient/cell-derived tumor xenografts (P/CDX) and spontaneous models induced by toxic substances are naturally heterogeneous in cellular composition during the time but are also highly personalized or unrepeatable. By contrast, transgenic cancer models provide definite genetic backgrounds via direct manipulation of oncogenic pathways; however, the tissue-specific modifications are usually on the whole organ level and poorly mimic the focal lesion(s) in the real cancer patients.

Zebrafish is a highly visualized vertebrate model animal, and liver is a conserved organ between zebrafish and human in morphology and anatomy ([Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}) ([@ref9]). The hepatocyte-specific promoter *fabp10a* has been extensively used to drive gene expression in zebrafish liver ([Supplementary Figure S1B](#sup1){ref-type="supplementary-material"}) ([@ref10]). We and other groups have employed zebrafish to generate several transgenic models of hepatic carcinoma as preclinical models, among which, a diversity of oncogenes, including *kras* ([@ref10]), swordtail fish *egfr (XMRK)* ([@ref3]), mouse *Myc* ([@ref10]), human *CTNNB1* ([@ref10]), and *HBX* ([@ref5]), were expressed in zebrafish hepatocytes and induced hepatic hyperplasia and eventually carcinoma. Here we propose three different strategies to model heterogeneous hepatic tumorigenesis in zebrafish to better mimic the focal lesion(s) in human cancer patients.

Firstly, we created heterogeneity by performing vector injection at single/double-cell stages. Zygote microinjection has been previously employed to generate chimera zebrafish for modeling tumor heterogeneity or for manipulating oncogenic driver ([@ref6]; [@ref7]). Here we injected a Tol2-flanked conditional expression vector *hsp70l:ABC-2A-tcf7l2* into *Tg(fabp10a:tetOn; tre:eGFP-kras^v12^;tcfsiam:mCherry)* zebrafish at single-cell stage. *fabp10a:tetOn* expresses the transcriptional factor TetOn, which induces the universal expression of eGFP-fused Kras in all hepatocytes. *tcfsiam:mCherry* is a classic reporter of the canonical Wnt signaling pathway ([@ref8]). *hsp70l:ABC-2A-tcf7l2* expressed the active human β-catenin (ABC) and zebrafish Tcf7l2 and activated the Wnt reporter in cells carrying vectors ([Figure 1A](#f1){ref-type="fig"}). After doxycycline (DOX) administration and heat shock, the cancerous liver in the injected larvae displayed a heterogeneous pattern that the Wnt signaling pathway was only activated in a proportion of the hepatocytes, which were labeled in red fluorescence ([Figure 1B](#f1){ref-type="fig"}).

![Schematic diagrams and images of zebrafish heterogeneous hepatic cancer models. (**A**) Schematic diagram of the double-transgenic zebrafish *Tg(fabp10a:tetOn; tre:eGFP-kras^v12^; tcfsiam:mCherry)* injected by *hsp70l:ABC-P2A-tcf7l2*. (**B**) Representative images of the whole mount view (left), left hepatic lobe (middle), and orthogonal views (optical sections, right) of a dissected liver of a 5 days post-fertilization (dpf) *Tg(fabp10a:tetOn; tre:eGFP-kras^v12^; tcfsiam:mCherry)* injected by *hsp70l:ABC-P2A-tcf7l2* (heat shock and DOX added at 3 dpf) (scale bar, 25 μm). (**C**) Schematic diagram of the triple-transgenic zebrafish *Tg(fabp10a:tetOn; tre:Gal4; UAS:ABC-P2A-tcf7l2; tcfsiam:eGFP)*. (**D**) Representative images of the lateral view optical sections/pseudo-color of a 5 dpf *Tg(fabp10a:tetOn; tre:Gal4; UAS:ABC-P2A-tcf7l2; tcfsiam:eGFP)* larva (DOX added at 3 dpf, left) and high-magnification images of cryo-sections in fluorescence and HE staining of a 10 dpf transgenic liver (DOX added at 4 dpf, right) (scale bar, 60 μm). (**E**) Schematic diagram of the double-transgenic zebrafish *Tg(fabp10a:tetOn; tre:Gal4; UAS:Oncobow)*. (**F**) Lateral views of a *Tg(fabp10a:tetOn; tre:Gal4; UAS:Oncobow)* zebrafish at 3 and 6 dpf in bright field and the liver under three different fluorescent channels (DOX added at 2 dpf) (scale bar, 150 μm). (**G**) Statistics of fluorescent populations in the liver of *Tg(fabp10a:tetOn; tre:Gal4; UAS:Oncobow)* zebrafish at 3 and 6 dpf (*n* = 5 per groups). (**H**) Representative images of a 10 dpf *Tg(fabp10a:tetOn; tre:Gal4; UAS:Oncobow)* in bright field (left above, DOX added at 4 dpf), the representative flow cytometry of the digested liver cells (left below), and high-magnification images of cryo-sections in fluorescence, HE staining, and SA-β-Gal staining (right) (scale bar, 150 μm). (**I**) mRNA expression of senescence-relevant genes in different hepatocyte populations of the 10 dpf *Tg(fabp10a:tetOn; tre:Gal4; UAS:Oncobow)* livers (*n* = 3 per assay). Data are represented as mean ± SD. Statistical differences were determined by one-way analysis of variance and Student's *t*-test. ^⋆⋆^*P* \< 0.01; ^⋆⋆⋆^*P* \< 0.001.](mjz083f1){#f1}

Besides, the heterogeneity can also be implemented in the stabilized transgenic lines. For example, a mifepristone-inducible Cre recombination system was previously employed to generate transgenic zebrafish models of hepatic carcinoma with mosaic patterns ([@ref4]). Here we provided an alternative strategy that the random silencing of the *UAS* promoter in the stabilized transgenic zebrafish can also produce a mosaic expression pattern ([@ref10]). Based on this phenomenon, we have generated a triple transgenic line that displayed chimeric expression of human *ABC* and zebrafish *tcf7l2* in the liver and carried a green fluorescent Wnt reporter *tcfsiam:eGFP*, *Tg(fabp10:tetOn; tre:Gal4-VP16; UAS:ABC-2A-tcf7l2; tcfsiam:eGFP)* ([Figure 1C](#f1){ref-type="fig"}). The Wnt reporter *tcfsiam:eGFP* is activated by both the endogenous and ectopic/exogenous β-catenin and Tcf7l2. Compared to the normal zebrafish liver that barely has any Wnt activity ([@ref10]), the triple transgenic zebrafish liver displayed significant mosaic green fluorescence/Wnt activity in hepatocytes after DOX administration, indicating the establishment of genetic heterogeneity in the partially cancerous liver ([Figure 1D](#f1){ref-type="fig"}). Besides, the hematoxylin-eosin (HE) staining on the adjacent cryo-sections revealed that both the cell density and nucleo-cytoplasmic ratio were increased in the Wnt active regions.

In addition, other conditional transgenic designs can be modified to display heterogeneity in stabilized zebrafish lines. 'Brainbow' tool box provided high-level heterogeneity in fluorescence for cell lineages tracing at complex *in vivo* environments ([@ref1]). Here we fused oncogenes *kras^v12^* and murine *Myc* before two fluorescent proteins of the brainbow cascades and generated a novel transgenic cascade termed 'Oncobow'. Oncobow was then packed into an Tol2-flanked expression vector driven by a *UAS* promoter and integrated into *Tg(fabp10:tetOn; tre:Gal4-VP16)* background. The hepatocytes of the double transgenic larvae *Tg(fabp10a:tetOn; tre:Gal4; UAS:Oncobow)* expressed different oncogenes in the hepatocyte populations upon DOX administration, and the oncogenic heterogeneity was visualized by the colorful fluorescence, which may allow us to monitor the dynamics of tumorigenesis at single-cell resolution ([Figure 1E](#f1){ref-type="fig"}). To investigate the behaviors of the heterogeneous populations, we took images on the same 'Oncobow' zebrafish at two different time points (3 and 6 dpf (days post-fertilization)) and measured the sizes of the different fluorescent populations ([Figure 1F](#f1){ref-type="fig"}). The statistics indicated that the cell populations with different genetic backgrounds displayed a diversity of pattern changes, the phiYFP-positive/*kras^v12^*-expressing population expanded faster than the mKate2-positive/*Myc*-expressing population and the cyan fluorescent protein (CFP)-positive population ([Figure 1G](#f1){ref-type="fig"}). Previously, we reported that Ras oncogenic insults induced the accumulation of β-galactosidase in zebrafish hepatocytes ([@ref10]); here, we also observed the increased SA-β-Gal staining in the liver regions with phiYFP fluorescence but not the regions with mKate2 and CFP fluorescence ([Figure 1H](#f1){ref-type="fig"}). To further investigate the differences in senescence of distinct populations at transcriptional level, we performed cell sorting and harvested the hepatocytes carrying three different fluorescence for analyzing mRNA expression ([Figure 1H](#f1){ref-type="fig"}). The results showed that the senescence-relevant genes *glb1*, *cdkn1a*, and *mcm2* were significantly deregulated in the *kras^v12^*-expressing hepatocytes as expected in senescence. However, the expression of *cdkn2a/b* (homologs of the human *CDKN2A*) was not detected, and *lmnb1* was increased in the *kras^v12^*-expressing hepatocytes, which is opposite to its downregulation in cells experiencing classical senescence. Therefore, the accumulation of β-galactosidase may be insufficient to define the status of the *kras^v12^*-expressing hepatocytes as senescence.

Altogether, the three transgenic strategies in combination of the transparency and small size in zebrafish will allow us to better mimic and understand cancer heterogeneity, serving as novel tools for exploring the development of and therapeutic options for solid tumor focal environment *in vivo.\[[Supplementary material](#sup1){ref-type="supplementary-material"} is available at Journal of Molecular Cell Biology online. This work was supported by the National Natural Science Foundation of China (81402582) and the Natural Science Foundation of Shanghai (14YF1400600 and 18ZR1404500).\]*
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